(¿Â¶óÀÎ) ´ëÇѾȰúÇÐȸ Á¦126ȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾Æ.ÅÂÆò¾ç ¾È¿µ»óÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2021-10-30±³À°ÀÏÀÚ : 2021-10-30
±³À°Àå¼Ò : ¿Â¶óÀÎ(¿ÀÇÁ¶óÀÎ.±×·£µå¿öÄ¿Èú ¼¿ïÈ£ÅÚ)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) ´ëÇѾȰúÇÐȸ Á¦126ȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾Æ.ÅÂÆò¾ç ¾È¿µ»óÇÐȸ Çмú´ëȸ(2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѾȰúÇÐȸ
´ã´çÀÚ : Àü¹Ì¼÷
¿¬¶ôó : 02-3487-8055
À̸ÞÀÏ :
kos@ophthalmology.org ±³À°Á¾·ù : ¾È°ú
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í Á¤È¸¿ø ȸºñ ¹Ì³³È¸¿ø / 3Àϵî·Ï 80,000¿ø / 3ÀÏ-´çÀϿ¶óÀεî·Ï 100,000¿ø /1Àϵî·Ï 60,000¿ø / 1ÀÏ-´çÀÏ ¿Â¶óÀεî·Ï 80,000¿øÁ¤È¸¿ø ȸºñ ³³ºÎȸ¿ø 3Àϵî·Ï 55,000¿ø / 3ÀÏ-´çÀÏ ¿Â¶óÀÎ 75,000¿ø / »çÀü-1Àϵî·Ï 40.000¿ø / 1ÀÏ-´çÀÏ ¿Â¶óÀÎ µî·Ï 60,000¿øÁØȸ¿ø ȸºñ ¹Ì³³È¸¿ø 3Àϵî·Ï 50,000¿ø / 3ÀÏ-´çÀϿ¶óÀÎ 70,000¿ø /»çÀü-1Àϵî·Ï 35,000¿ø / ´çÀÏ-1Àϵî·Ï 55,000¿ø - °ü°èÀÚ ¾È°úº´(ÀÇ)¿ø Á¾»çÀÚ(°£È£»çÆ÷ÇÔ), °ü·Ã¾÷ü Á¾»çÀÚ »çÀü-35,000¿ø/ ÇöÀå - 55,000¿ø Ÿ°ú ÀÇ»ç 3Àϵî·Ï »çÀü-100,000¿ø / ÇöÀå-120,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-30 walker hall 08:50~09:05 Rescue patients who have poor vision and double vision ½ÅÇöÁø(°Ç±¹ÀÇ´ë)
Åä·Ð 10-30 walker hall 09:05~09:10 Discussion ()
±³À°½Ã°£ 10-30 walker hall 09:10~09:25 Rescue patients with drooping eyelid Á¶¿ø°æ(°¡Å縯ÀÇ´ë)
Åä·Ð 10-30 walker hall 09:25~09:30 Discussion ()
±³À°½Ã°£ 10-30 walker hall 09:30~09:45 Rescue patients with an eye injury ÀÌÈ(°í·ÁÀÇ´ë)
Åä·Ð 10-30 walker hall 09:45~09:50 Discussion ()
±³À°½Ã°£ 10-30 walker hall 09:50~10:05 Rescue patients with COVID-19 À̹ÎÁ¤(ÇѸ²ÀÇ´ë)
Åä·Ð 10-30 walker hall 10:05~10:20 Discussion ()
ÈÞ½Ä 10-30 walker hall 10:20~10:30 break ()
±³À°½Ã°£ 10-30 walker hall 10:30~10:45 Causes and epidemiology of myopia ¹Ú°æ¾Æ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10-30 walker hall 10:45~11:00 Glasses and CLs to slow progression of myopia ¹Ú½ÅÇý(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-30 walker hall 11:00~11:15 Pharmacologic interventions to slow progression of myopia ÇÑÁø¿ì(¿¬¼¼ÀÇ´ë)
Åä·Ð 10-30 walker hall 11:15~11:25 Discussion ()
±³À°½Ã°£ 10-30 walker hall 11:25~11:45 LAMP Study and clinical experience in Hong Kong Jason C. Yam(Chinese University)
Åä·Ð 10-30 walker hall 11:45~12:00 Discussion ()
ÈÞ½Ä 10-30 walker hall 12:00~13:00 break ()
±³À°½Ã°£ 10-30 walker hall 13:00~13:15 Non-neovascular AMD À±Ã¶¹Î(°í·ÁÀÇ´ë)
±³À°½Ã°£ 10-30 walker hall 13:15~13:30 Neovascular AMD ±èÀçÈÖ(±è¾È°úº´¿ø)
±³À°½Ã°£ 10-30 walker hall 13:30~13:45 Diabetic retinopathy ½ÅÁÖ¿µ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-30 walker hall 13:45~14:00 Retinal vascular occlusion ±è¼ºÅÃ(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 10-30 walker hall 14:00~14:15 Vitreomacular interface disorders ±èÀ±Àü(¿ï»êÀÇ´ë)
±³À°½Ã°£ 10-30 walker hall 14:15~14:30 Intraocular tumor ±è¹Î(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 10-30 walker hall 14:30~14:40 break ()
±³À°½Ã°£ 10-30 walker hall 14:40~14:49 Association between epiretinal membrane, epiretinal proliferation, and prognosis of full-thickness macular hole closure ¾çÁö¸í(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 10-30 walker hall 14:49~14:58 Influence of mild non-foveal involving epiretinal membrane on visual quality in eyes with multifocal intraocular lens implantation Àü¼ÒÈñ(Ä«À̾Ȱú)
±³À°½Ã°£ 10-30 walker hall 14:58~15:07 Inferior Staphyloma with Subretinal Fluid: Treatment Response and Long-term Effect of Anti-VEGF and Photodynamic Therapy(PDT) ÀüÀç¿ø(¿¬¼¼´ëÇб³ °³²¼¼ºê¶õ½ºº´¿ø ¾È°úÇб³½Ç)
±³À°½Ã°£ 10-30 walker hall 15:07~15:16 Laser and Anti-Vascular Endothelial Growth Factor Treatment for Drusenoid Pigment Epithelial Detachment in Age-Related Macular Degeneration: 24-Month Outcomes ±èÇü¹Î(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾È°úÇб³½Ç ºÐ´ç¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 10-30 walker hall 15:16~15:25 Analysis of cluster with age‑related macular degeneration or pachychoroid spectrum diseases based on choroidal thickness profle °ÇüÁÖ(°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¾È°úÇб³½Ç)
±³À°½Ã°£ 10-30 walker hall 15:25~15:34 Capillary Congestion and Its Association with Recurrence of Macular Edema in Chronic Branch Retinal Vein Occlusion °¹Î½Â(ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¾ç»êºÎ»ê´ëÇб³º´¿ø ¾È°úÇб³½Ç)
±³À°½Ã°£ 10-30 walker hall 15:34~15:40 Multiple Retinal Hemorrhages with Retinal Vein Thrombosis after a COVID-19 Vaccination Ȳ±ÔÀº(¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ ¾È°úÇб³½Ç ¼øõÇâ´ëÇб³ ºÎ¼Ó õ¾Èº´¿ø)
±³À°½Ã°£ 10-30 walker hall 15:40~15:48 Evaluation of astigmatic correction using vector analysis after combined Femtosecond Laser-Assisted Phacoemulsification and Intrastromal Arcuate Keratotomy: 1-year outcome. Su Young Moon(Asan Medical Center)
±³À°½Ã°£ 10-30 walker hall 15:48~15:56 Comparison of Visual Outcomes and Complications of Phacoemulsification with Intraocular Lens Implantation between Nanophthalmos and Normal Eyes. Saksakul Engchuan(Mettapracharak (Wat Raikhing) Hospital)
±³À°½Ã°£ 10-30 walker hall 15:56~16:04 A Novel Virtual Wet Lab - Using a Smartphone Camera Adapter and a Video Conference Platform to Provide Real-Time Surgical Instruction Erik Hellier(Eversight Ann Arbor MI)
±³À°½Ã°£ 10-30 walker hall 16:04~16:12 Topography of the orbital part of the lacrimal gland for treating epiphora using botulinum toxin injection Hyun Jin Shin(Konkuk University Medical Center)
±³À°½Ã°£ 10-30 walker hall 16:12~16:20 Predictive factors for the severity of Graves¡¯ orbitopathy in patients with newly diagnosed Graves¡¯ disease. Seunghyun Lee(CHA Bundang Medical Center)